Your browser doesn't support javascript.
loading
IL-38, a potential therapeutic agent for lupus, inhibits lupus progression.
Xu, Wang-Dong; Su, Lin-Chong; Fu, Lu; Lan, You-Yu; Liu, Xiao-Yan; Huang, Qi; Wu, Qian; Zhou, Jie; Huang, An-Fang.
Afiliação
  • Xu WD; Department of Evidence-Based Medicine, Southwest Medical University, 1 Xianglin Road, Luzhou, 646000, Sichuan, China.
  • Su LC; Department of Rheumatology and Immunology, Minda Hospital of Hubei Minzu University, 2 Wufengshan Road, Enshi, 445000, Hubei, China.
  • Fu L; Laboratory Animal Center, Southwest Medical University, 1 Xianglin Road, Luzhou, 646000, Sichuan, China.
  • Lan YY; Department of Rheumatology and Immunology, Affiliated Hospital of Southwest Medical University, 25 Taiping road, Luzhou, 646000, Sichuan, China.
  • Liu XY; Department of Evidence-Based Medicine, Southwest Medical University, 1 Xianglin Road, Luzhou, 646000, Sichuan, China.
  • Huang Q; Department of Evidence-Based Medicine, Southwest Medical University, 1 Xianglin Road, Luzhou, 646000, Sichuan, China.
  • Wu Q; Department of Evidence-Based Medicine, Southwest Medical University, 1 Xianglin Road, Luzhou, 646000, Sichuan, China.
  • Zhou J; Department of Evidence-Based Medicine, Southwest Medical University, 1 Xianglin Road, Luzhou, 646000, Sichuan, China.
  • Huang AF; Department of Rheumatology and Immunology, Affiliated Hospital of Southwest Medical University, 25 Taiping road, Luzhou, 646000, Sichuan, China. loutch211@163.com.
Inflamm Res ; 71(7-8): 963-975, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35776155

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-1 / Lúpus Eritematoso Sistêmico Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-1 / Lúpus Eritematoso Sistêmico Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article